Amalgent Therapeutics, Inc.

About Amalgent Therapeutics, Inc.

Amalgent Therapeutics is developing combination analgesics that significantly lower the required dosages for effective pain relief by utilizing targeted pharmacological mechanisms. This approach aims to minimize side effects and enhance patient compliance in pain management therapies.

What does Amalgent Therapeutics, Inc. do?

Amalgent Therapeutics is developing combination analgesics that significantly lower the required dosages for effective pain relief by utilizing targeted pharmacological mechanisms. This approach aims to minimize side effects and enhance patient compliance in pain management therapies.

When was Amalgent Therapeutics, Inc. founded?

Amalgent Therapeutics, Inc. was founded in 2020.

How much funding has Amalgent Therapeutics, Inc. raised?

Amalgent Therapeutics, Inc. has raised 250000.

Founded
2020
Funding
250000
Employees
2 employees
Major Investors
North Carolina Biotechnology Center

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Amalgent Therapeutics, Inc.

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Amalgent Therapeutics is developing combination analgesics that significantly lower the required dosages for effective pain relief by utilizing targeted pharmacological mechanisms. This approach aims to minimize side effects and enhance patient compliance in pain management therapies.

amalgent.com100+
cb
Crunchbase
Founded 2020

Funding

$

Estimated Funding

$100K+

Major Investors

North Carolina Biotechnology Center

Team (<5)

No team information available.
Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.